Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Rockwell Medical (RMTI) over the last 6 years, with Dec 2024 value amounting to $559,000.

  • Rockwell Medical's Amortizatization of Intangibles fell 21.58% to $109,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $525,000, marking a year-over-year decrease of 6.58%. This contributed to the annual value of $559,000 for FY2024, which is 1.06% down from last year.
  • Per Rockwell Medical's latest filing, its Amortizatization of Intangibles stood at $559,000 for FY2024, which was down 1.06% from $565,000 recorded in FY2023.
  • Over the past 5 years, Rockwell Medical's Amortizatization of Intangibles peaked at $2.0 million during FY2022, and registered a low of $559,000 during FY2024.
  • Over the past 3 years, Rockwell Medical's median Amortizatization of Intangibles value was $565,000 (recorded in 2023), while the average stood at $1.0 million.
  • As far as peak fluctuations go, Rockwell Medical's Amortizatization of Intangibles grew by 26.94% in 2021, and later slumped by 71.93% in 2023.
  • Over the past 5 years, Rockwell Medical's Amortizatization of Intangibles (Yearly) stood at $1.5 million in 2020, then increased by 26.94% to $1.8 million in 2021, then climbed by 8.99% to $2.0 million in 2022, then tumbled by 71.93% to $565,000 in 2023, then declined by 1.06% to $559,000 in 2024.